Opinion|Videos|July 29, 2024
Decision-Making in CLL: The Role of Real-World Evidence
A discussion on therapeutic decision-making in CLL and the role of real-world evidence.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How do you integrate real-world evidence into your clinical decision-making process for BTK inhibitors in CLL?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
2
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain
3
Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis
4
Comprehensive Smoke-Free Laws Linked to Sustained Drop in CVD Mortality
5